June 30, 2020
Goldfinch Bio
Goldfinch Bio Secures $100 Million in Series B Financing
June 29, 2020
Blueprint Medicines
Blueprint Medicines Announces Publication in The Lancet Oncology Showing Durable Clinical Benefits of AYVAKIT™ (avapritinib) in NAVIGATOR Trial Patients with PDGFRA D842V Mutant GIST
June 25, 2020
GBT
GBT Awards $250,000 in ACCEL Grants to Advance Access to Care for People Living with Sickle Cell Disease
June 25, 2020
Nurix
Nurix Therapeutics Announces Formation Of DeCART Therapeutics To Advance New CAR T Therapies Using Targeted Protein Modulation
June 24, 2020
Fulcrum Therapeutics
Fulcrum Therapeutics Announces Initiation of Multi-Center Phase 3 (LOSVID) Trial with Losmapimod for Hospitalized COVID-19 Patients